Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

NCT00053105 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

INDUSTRY

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: cisplatin
DRUG: cytarabine
DRUG: methylprednisolone
DRUG: pixantrone dimaleate

Sponsor

Theradex